Skip to content
Kalpvruksh Markets
Offline Log in

THYROCARENSEOffline

THYROCARE TECH. · INE594H01019 · Small Cap · #679
489.75−5.75 (−1.16%)last close · 05 Nov 2026
Prev close
495.50
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹6,981 cr
52-week range · to 05 Nov 2026349.55649.35

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

THYROCARE is 25% below its 52-week high, above its 200-day average — a Small Cap company, #679 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 25% below its 52-week high
  • −16.6% vs Nifty 500
  • traded value 4.4× usual · delivery 47% vs 53% usual
  • FPI +3.9 pp · DII +5.0 pp · MF schemes in Sept 2026: 5 bought, 7 cut · no promoter pledge · insiders net bought ₹0 cr in 3 months · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹6,981 cr
Rank
#679
Cap band
Small Cap
Nearest cut-off — Mid / Small
−79.58% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.5×
median 2,68,558
Delivered
4,08,753
Of volume
69%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−5.0%−10.2 pts—
1 month−7.6%−11.6 pts—
3 months−18.4%−16.6 pts—
6 months+5.9%+5.5 pts—
1 year+9.1%+11.9 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+0.8%
above
vs 50-day average
−8.1%
below
vs 200-day average
+0.5%
above
ATR (14)
5.4%
typical daily range
Volatility
59%
1 month, annualised
Beta
0.67
vs Nifty 500, 1 year
Traded value
4.4×
vs usual
Delivery
47%
usual 53%
From the 52-week high
−24.6%
place in range 47% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters60.9%60.9%60.9%51.0% −9.9
FPI5.0%5.4% +0.45.4% +0.19.4% +3.9
Mutual funds18.6%19.4% +0.819.9% +0.422.9% +3.1
Other DII1.9%1.6% −0.41.1% −0.53.0% +1.9
Individuals10.9%10.2% −0.710.3% +0.210.9% +0.6
Others2.7%2.5% −0.22.4% −0.22.8% +0.4

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 100.0%Sep 25 85.8%Dec 25 100.0%Mar 26 100.0%Jun 26 100.0%Sep 26 none

Holders

Sep 26

All shareholders
75,186
Individuals
70,675

Indian passive funds’ stake

2026-06-30

Of free float
0.28%
Of all shares
0.11%
Schemes
9
Days to unwind
0.3
at 100% of volume

1,74,851 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
33
9 index · 24 active
Bought more
8
Sold some
9
FundSharesChangeDid
WOC Pharma and Healthcare Fund-Reg(G)Active+35,114+14.2%bought
Samco Special Opportunities Fund-Reg(G)Active−25,378−31.6%sold
Shriram Flexi Cap Fund-Reg(G)Active−10,790−26.5%sold
Shriram ELSS Tax Saver Fund-Reg(G)Active−3,830−26.0%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26391461+0.2%₹1,939 cr
Aug 263991264+18.7%₹2,191 cr
Jul 263483103−2.0%₹1,769 cr
Jun 26293682−0.4%₹1,711 cr
May 26281360+0.9%₹1,584 cr
Apr 26270520+0.2%₹1,242 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
Bought ₹0.01 cr (1)
Sold ₹0 (0)
Others
Bought ₹0.09 cr (1)
Sold ₹0 (0)
Latest 5 of 75 disclosures
0 selected
02 Nov 2026Brijesh KumarKMPBuy330₹0.01 cr0.00%Market Purchase
17 Aug 2026Docon Technologies Private LimitedPromoterPledge7,94,69,696₹4,916 cr0.51%Pledge Release
13 Aug 2026Docon Technologies Private LimitedPromoterSell26,01,039₹163 cr0.51%Market Sale
13 Aug 2026Docon Technologies Private LimitedPromoterSell1,31,68,657₹815 cr0.53%Block Deal
11 Aug 2026Docon Technologies Private LimitedPromoterPledge1,75,00,000₹1,089 cr0.61%Pledge Release

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Thyrocare Technologies Limited has submitted to the Exchange, outcome of board meeting held on October 29, 2026, inter-alia considered and approved the un-audited financial results for the quarter and half year ended September 30, 2026.
    29 Oct 2026
  • Takeover (SAST)
    APt Holdings limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
    04 Sept 2026
  • Takeover (SAST)
    Docon Technologies Private Ltd has submitted to  the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    18 Aug 2026
  • Takeover (SAST)
    Thyrocare Technologies Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    18 Aug 2026
  • Takeover (SAST)
    Docon Technologies Private Ltd has submitted to  the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
    17 Aug 2026
  • Pledge
    Thyrocare Technologies Limited has informed the Exchange regarding 'Communication Received From Promoter Regarding Release Of Pledge On Equity Shares Of Thyrocare Technologies Limited'.
    17 Aug 2026
  • Bulk deal: SELL
    10,00,000 at ₹631.71 — DOCON TECHNOLOGIES PRIVATE LIMITED
    13 Aug 2026
  • Bulk deal: SELL
    1,31,68,657 at ₹624 — DOCON TECHNOLOGIES PRIVATE LIMITED
    13 Aug 2026
  • Bulk deal: BUY
    13,21,363 at ₹624 — DSP MUTUAL FUND
    13 Aug 2026
  • Bulk deal: BUY
    29,99,731 at ₹624 — HSBC MUTUAL FUND
    13 Aug 2026

Latest shown; 12 in six months on all disclosures.

THYROCARE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹7Final23 Jun 202623 Jun 2026
EarlierBonus2:1—28 Nov 202528 Nov 2025
EarlierDividend₹7Interim24 Oct 202524 Oct 2025
EarlierDividend₹21Final25 Jul 202525 Jul 2025
EarlierDividend₹18Final16 Aug 202416 Aug 2024
EarlierDividend₹18Interim20 Apr 202320 Apr 2023
EarlierDividend₹15Interim11 May 202212 May 2022

7 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.